Hepatic macrophages: Key players in the development and progression of liver fibrosis

D Cheng, J Chai, H Wang, L Fu, S Peng… - Liver …, 2021 - Wiley Online Library
Hepatic fibrosis is a common pathological process involving persistent liver injury with
various etiologies and subsequent inflammatory responses that occur in chronic liver …

Therapeutic targeting of hepatic macrophages for the treatment of liver diseases

D van der Heide, R Weiskirchen, R Bansal - Frontiers in immunology, 2019 - frontiersin.org
Hepatic macrophages play a central role in maintaining homeostasis in the liver, as well as
in the initiation and progression of liver diseases. Hepatic macrophages are mainly derived …

The molecular mechanisms of liver fibrosis and its potential therapy in application

D Zhang, Y Zhang, B Sun - International Journal of Molecular Sciences, 2022 - mdpi.com
Liver fibrosis results from repeated and persistent liver damage. It can start with hepatocyte
injury and advance to inflammation, which recruits and activates additional liver immune …

Targeting of hepatic macrophages by therapeutic nanoparticles

CI Colino, JM Lanao, C Gutierrez-Millan - Frontiers in immunology, 2020 - frontiersin.org
Hepatic macrophage populations include different types of cells with plastic properties that
can differentiate into diverse phenotypes to modulate their properties in response to different …

Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function

M Uzhytchak, B Smolková, M Lunova, A Frtús… - Advanced Drug Delivery …, 2023 - Elsevier
Although several nanomedicines got clinical approval over the past two decades, the clinical
translation rate is relatively small so far. There are many post-surveillance withdrawals of …

Monocyte-endothelial cell interactions in vascular and tissue remodeling

M Medrano-Bosch, B Simón-Codina… - Frontiers in …, 2023 - frontiersin.org
Monocytes are circulating leukocytes of innate immunity derived from the bone marrow that
interact with endothelial cells under physiological or pathophysiological conditions to …

Multifunctional nanoparticles boost cancer immunotherapy based on modulating the immunosuppressive tumor microenvironment

J Li, M Zhao, M Sun, S Wu, H Zhang… - ACS Applied Materials …, 2020 - ACS Publications
Cancer immunotherapy has been a favorable strategy for facilitating antitumor immunity.
However, immune tolerance and an ultimate immunosuppressive tumor microenvironment …

Polymeric nanomedicines for the treatment of hepatic diseases

F Luo, Y Yu, M Li, Y Chen, P Zhang, C Xiao… - Journal of …, 2022 - Springer
The liver is an important organ in the human body and performs many functions, such as
digestion, detoxification, metabolism, immune responses, and vitamin and mineral storage …

BTN2A1 targeting reprograms M2-like macrophages and TAMs via SYK and MAPK signaling

C Kerneur, E Foucher, JG Casas, M Colazet, KS Le… - Cell Reports, 2024 - cell.com
Summary Tumor-associated macrophages (TAMs), often adopting an immunosuppressive
M2-like phenotype, correlate with unfavorable cancer outcomes. Our investigation unveiled …

[HTML][HTML] Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and …

DW Kurniawan, R Booijink, L Pater, I Wols… - Journal of controlled …, 2020 - Elsevier
Liver diseases are the growing health problem with no clinically approved therapy available.
Activated hepatic stellate cells (HSCs) are the key driver cells responsible for extracellular …